摘要 |
the N-oxide forms, the pharmaceutically acceptable addition salts and the stereochemically isomeric forms thereof, wherein X represents C or N; Y represents C or N; L represents a methyl or a direct bond; Z<SUP>1 </SUP>represents a direct bond, C<SUB>1-2</SUB>alkyl- or a divalent radical of formula -CH<SUB>2</SUB>-CH- (a) or -CH- (b); Z<SUP>2 </SUP>represents a direct bond, C<SUB>1-2</SUB>alkyl- or a divalent radical of formula -CH<SUB>2</SUB>-CH- (a) or -CH- (b); R<SUP>1 </SUP>represents hydrogen, halo, cyano, amino, phenyl, hydroxy, C<SUB>1-4</SUB>alkyloxycarbonyl, hydroxycarbonyl, NR<SUP>3</SUP>R<SUP>4 </SUP>or C<SUB>1-4</SUB>alkyl optionally substituted with one or more substituents selected from hydroxycarbonyl, phenyl, C<SUB>1-4</SUB>alkyloxy or NR<SUP>5</SUP>R<SUP>6 </SUP>or R<SUP>1 </SUP>represents C<SUB>1-4</SUB>alkyloxy- optionally substituted with one or more substituents selected from hydroxycarbonyl, phenyl, C<SUB>1-4</SUB>alkyloxy or NR<SUP>7</SUP>R<SUP>8</SUP>; R<SUP>2 </SUP>represents hydrogen, halo, C<SUB>1-4</SUB>alkyl or C<SUB>1-4</SUB>alkyloxy-; R<SUP>3 </SUP>and R<SUP>4 </SUP>each independently represent hydrogen, C<SUB>1-4</SUB>alkyl or C<SUB>1-4</SUB>alkylcarbonyl-; R<SUP>5 </SUP>and R<SUP>6 </SUP>each independently represent hydrogen, C<SUB>1-4</SUB>alkyl or C<SUB>1-4</SUB>alkylcarbonyl-; R<SUP>7 </SUP>and R<SUP>8 </SUP>each independently represent hydrogen, C<SUB>1-4</SUB>alkyl or C<SUB>1-4</SUB>alkylcarbonyl-; A represents phenyl or a monocyclic heterocycle selected from the group consisting of thiophenyl, furanyl, oxazolyl, thiazolyl, imidazolyl, isoxazolyl, isothiazolyl, pyrridinyl, pyridazinyl, pyrimidinyl and piperazinyl.
|